Satin Creditcare shareholders approve NCD issuance and MD pay revision
Satin Creditcare Network Limited concluded its 36th AGM on August 7, 2026, with shareholders approving key strategic initiatives including NCD issuance and MD remuneration revision. The audited financials for FY26 were adopted without adverse remarks, and Director Satvinder Singh was re-appointed by rotation.

*this image is generated using AI for illustrative purposes only.
Satin Creditcare shareholders have approved the issuance of Non-Convertible Debentures (NCDs) and a revision in the remuneration of Chairman cum Managing Director Dr Harvinder Pal Singh at the company’s 36th Annual General Meeting (AGM) held on August 7, 2026. The meeting, conducted via video conferencing, also saw the adoption of audited financial statements for FY26 and the re-appointment of Director Satvinder Singh. These approvals enable Satin Creditcare Network Limited to expand its debt funding capabilities while aligning executive compensation with its strategic objectives.
The AGM commenced at 11:00 a.m. (IST) with Dr H P Singh presiding. Independent Directors Anupam Kunal Gangaher and Ashok Kumar Sharma, along with Non-Executive Director Satvinder Singh, were present. Chief Financial Officer Amit Kumar Gupta and Group Controller Jugal Kataria represented senior management. Statutory auditor J C Bhalla & Co. and secretarial auditor DPV & Associates LLP were also in attendance. Scrutinizer Devesh Kumar Vasisht oversaw the e-voting process to ensure compliance with Section 108 of the Companies Act, 2013.
Shareholders voted on four resolutions during the meeting. The ordinary business included the adoption of standalone and consolidated financial statements for the financial year ended March 31, 2026. Both the Auditor’s Report and Secretarial Audit Report contained no adverse remarks. Additionally, shareholders approved the re-appointment of Satvinder Singh, who retires by rotation under Section 152(6) of the Companies Act, 2013.
Key Resolutions Passed
| Resolution Type | Description | Status |
|---|---|---|
| Ordinary | Adoption of Audited Financial Statements for FY26 | Approved |
| Ordinary | Re-appointment of Satvinder Singh as Director | Approved |
| Special | Issuance of NCDs via Private Placement | Approved |
| Special | Revision in Remuneration of Dr H P Singh | Approved |
The special business segment focused on capital structure and executive compensation. The Board recommended issuing NCDs in one or more series or tranches on a private placement basis. Shareholders also approved the remuneration revision for Dr Harvinder Pal Singh. Voting by five promoters holding 3,95,54,351 equity shares was excluded from this resolution as per regulatory requirements.
Voting Results Breakdown
The e-voting window was open from August 4, 2026, at 9:00 a.m. (IST) until August 6, 2026, at 5:00 p.m. (IST), with an additional 15-minute facility during the AGM. Central Depository Services (India) Limited (CDSL) facilitated the electronic voting. As of the cut-off date of July 31, 2026, the total paid-up share capital was ₹110.47 crore, divided into 1,10,47,09,650 equity shares of face value ₹10 each.
| Resolution | Votes In Favour (%) | Votes Against (%) | Outcome |
|---|---|---|---|
| Adoption of Financials | 99.999998% | 0.000002% | Passed |
| Re-appointment of S. Singh | 99.717651% | 0.282349% | Passed |
| NCD Issuance | 99.900042% | 0.099958% | Passed |
| MD Remuneration Revision | 94.002603% | 5.997397% | Passed |
What the Numbers Show
The near-unanimous approval of the NCD issuance (99.9%) signals strong shareholder confidence in Satin Creditcare’s debt expansion strategy. The clean audit opinion for FY26 reinforces financial reporting integrity. While the MD remuneration revision faced slightly higher dissent (6%) compared to other resolutions, it still secured substantial support (94%), indicating alignment between leadership compensation and shareholder interests despite the exclusion of promoter votes.
Historical Stock Returns for Satin Creditcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.72% | -1.44% | -6.76% | +46.04% | +49.58% | 0.0% |
How will the proceeds from the newly approved NCD issuance be allocated across Satin Creditcare's loan book segments, and what is the expected impact on its debt-to-equity ratio?
Given the 6% dissent against the MD remuneration revision, are there emerging governance concerns among minority shareholders regarding executive pay structures in the NBFC sector?
What specific strategic initiatives or market expansions is Satin Creditcare planning to fund with this enhanced debt capacity, and how does this align with FY27 growth targets?


































